A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
Clinical trial NCT07309055 · RECRUITING
Trial details
- NCT number
- NCT07309055
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-21
- Primary completion
- 2027-11-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.